InvestSMART

Proteomics International Laboratories Ltd (ASX: PIQ) - Announcements

- Current share price for PIQ : $0.115

ASX company news and announcements for Proteomics International Laboratories Ltd (PIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Proteomics International Laboratories Ltd (PIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Proteomics International Laboratories Ltd (PIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Proteomics International Laboratories Ltd (PIQ)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$19 Proteomics International receives R&D Tax Incentive 18 Nov 2015 9:13AM $0.400 $0.115 fallen by 71.25%
$19 Appendix 3B - Issue of Shortfall Options 6 Nov 2015 1:42PM $0.425 $0.115 fallen by 72.94%
$19 Proteomics Targets Key Asian Markets 4 Nov 2015 10:01AM $0.405 $0.115 fallen by 71.60%
$19 Appendix 4C - September 2015 Quarterly Report 30 Oct 2015 3:36PM $0.480 $0.115 fallen by 76.04%
$19 Proteomics granted US Patent for Diagnostic Test 27 Oct 2015 9:16AM $0.340 $0.115 fallen by 66.18%
$19 Proteomics Technical Presentation 26 Oct 2015 10:12AM $0.320 $0.115 fallen by 64.06%
$19 Notice of Annual General Meeting/Proxy Form 20 Oct 2015 8:09PM $0.310 $0.115 fallen by 62.90%
$19 Initial Director's Interest Notice 19 Oct 2015 7:42PM $0.310 $0.115 fallen by 62.90%
$19 Change of Directors' Interest Notices 19 Oct 2015 7:28PM $0.310 $0.115 fallen by 62.90%
$19 Proteomics International Wins WA Industry and Export Award 19 Oct 2015 11:05AM $0.260 $0.115 fallen by 55.77%
$19 Change of Directors' Interest Notices 16 Oct 2015 8:04PM $0.260 $0.115 fallen by 55.77%
$19 Proteomics International Laboratories Appoints New Director 16 Oct 2015 5:15PM $0.260 $0.115 fallen by 55.77%
$19 Completion of Entitlement Issue and Shortfall notice 14 Oct 2015 6:00PM $0.240 $0.115 fallen by 52.08%
$19 Corporate Governance Statement and Appendix 4G 1 Oct 2015 8:10AM $0.250 $0.115 fallen by 54%
$19 Annual Report to shareholders 30 Sep 2015 7:21PM $0.250 $0.115 fallen by 54%
$19 Appendix 3B - Release from escrow 30 Sep 2015 5:03PM $0.250 $0.115 fallen by 54%
$19 Entitlement Issue Prospectus Despatch 21 Sep 2015 4:35PM $0.220 $0.115 fallen by 47.73%
$19 Release from escrow 16 Sep 2015 5:52PM $0.270 $0.115 fallen by 57.41%
$19 Letter to Ineligible Shareholders - Entitlement Issue 15 Sep 2015 6:44PM $0.295 $0.115 fallen by 61.02%
$19 Letter to Eligible Shareholders - Entitlement Issue 15 Sep 2015 6:40PM $0.295 $0.115 fallen by 61.02%
$19 Non-renounceable Pro-rata Options Entitlement Issue 14 Sep 2015 9:59AM $0.310 $0.115 fallen by 62.90%
$19 Letter to option holders - Entitlement Issue 11 Sep 2015 6:15PM $0.310 $0.115 fallen by 62.90%
$19 Appendix 3B - Entitlement Issue 11 Sep 2015 6:12PM $0.310 $0.115 fallen by 62.90%
$19 Entitlement Issue Prospectus 11 Sep 2015 5:51PM $0.310 $0.115 fallen by 62.90%
$19 Investor Presentation - September 2015 2 Sep 2015 12:25PM $0.320 $0.115 fallen by 64.06%

651 - 675 of 698 results

Page 27 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.